CION Ameerpet
A brain tumour diagnosis is frightening, and the first plan you hear is not always the only option. CION's tumour board reviews your MRI and pathology, checks the molecular tests, and explains everything in plain language — with no pressure to switch.
Hearing the words "brain tumour" is one of the hardest moments any family faces. In the rush that follows, it can feel as though the first plan you are offered is the only one. It usually is not. Brain tumours are unusually complex — the diagnosis, the WHO grade, and the molecular markers all shape the right treatment, and small differences in how the MRI or pathology is read can change everything.
A second opinion is simply a careful, independent look at your scans and reports by another experienced team. It is not a criticism of your first doctor, and it does not mean changing hospitals. At CION Cancer Clinics, our brain cancer and tumour team reviews your case against current NCCN and EANO guidance, then gives you a written second opinion you can take anywhere — confidential, with no commitment to start treatment. You deserve to feel certain before you decide.
Major guideline bodies recognise that the diagnosis of a brain tumour can change on review. The European Association of Neuro-Oncology (EANO) and the National Comprehensive Cancer Network (NCCN) both stress that an accurate integrated diagnosis — combining how the tumour looks under the microscope with molecular markers such as IDH mutation, MGMT methylation, and 1p/19q co-deletion — is essential before treatment is planned. If those markers were never tested, a second opinion that arranges them can genuinely change the recommended plan.
You do not need a special reason to ask for a review — but in these situations a second look tends to make the biggest difference. If any of these describe your situation, it is worth talking to us before treatment begins.
For a malignant glioma, markers such as IDH mutation, MGMT methylation, and 1p/19q co-deletion are central to planning. If your report does not mention them, a second opinion can arrange the testing — and the results may point to a different, gentler, or more effective approach.
When a tumour sits close to areas controlling speech or movement, the goal is the safest possible removal. We discuss safe-resection planning and, where needed, coordinate the surgery with accredited neurosurgical partners — so you understand the trade-offs clearly.
For a limited number of secondary tumours, focused stereotactic radiosurgery is often preferred because it tends to protect memory and thinking better than whole-brain radiation. If this option was not discussed, a review is reasonable. Brain metastases often start in the lung, breast, kidney, or skin.
Feeling uncertain is reason enough. Most brain tumour plans allow a short, deliberate pause to confirm the diagnosis. A calm explanation in plain language — what the MRI and pathology report actually mean — often brings the clarity families are looking for.
Our second opinion is led by a medical oncologist and a radiation oncologist, supported by radiology and neuropathology where a re-read helps, and discussed by our multidisciplinary tumour board. We focus on what we deliver directly and are honest about what we coordinate with partners.
Want to see who will look at your case? Meet our brain cancer specialists in Hyderabad, or request a free second opinion now.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
A second opinion is a review, not a commitment. We walk this journey with you — confirming the diagnosis and explaining your options clearly, before you decide anything.
A second opinion should feel organised and reassuring, not stressful. Here is exactly what happens from the moment you reach out, so you know what to expect and what to gather.
Two parts of a brain tumour work-up most often shift the recommended treatment when reviewed: the imaging and the molecular markers. A second opinion checks both carefully.
A brain MRI with contrast is the cornerstone of diagnosis. A second-read by an experienced radiologist may notice the tumour's exact location, its relationship to critical structures, or subtle features that suggest a different likely diagnosis than first reported. The original images matter far more than the printed report — which is why we ask for the scans themselves. If you want to understand what your scan shows, our guide to understanding your brain MRI and pathology report walks through it in plain language.
For malignant gliomas, molecular markers are not optional extras — they define the diagnosis under the current WHO classification. IDH mutation status strongly affects prognosis; MGMT promoter methylation helps predict response to alkylating chemotherapy; and 1p/19q co-deletion identifies oligodendroglioma. If these were not tested, we can usually arrange them on your existing biopsy sample — and the results may meaningfully change what is recommended.
Under the 2021 WHO Classification of Tumours of the Central Nervous System, many brain tumours are now defined by their molecular markers, not just how the cells look under the microscope. As EANO guidelines describe, the same-looking tumour can carry a different diagnosis and outlook depending on markers such as IDH and 1p/19q. This is exactly why a second opinion that re-checks the pathology and molecular testing can be so valuable.
Bring as much as you have — but do not delay your review if something is missing. The most useful records are:
Not sure what you have, or how to share it? That's completely normal — we'll guide you through it. Reach our brain tumour team for brain tumour treatment in Hyderabad, or start your review now.
A second opinion rarely needs to cause delay — but some symptoms always need urgent, in-person medical care first. Seek emergency attention right away, before arranging any review, if you experience:
Once you are safe and stable, a calm, careful second opinion is one of the most useful steps you can take. We're here when you're ready — request your free written second opinion.
CION holds a 4.8/5 Google rating across 800+ reviews, with 15,000+ patients treated. Decisions for healing, not billing — that's how we approach every second opinion.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.A second opinion is especially valuable in a few clear situations. First, if a malignant glioma was diagnosed but molecular testing (IDH mutation, MGMT methylation, 1p/19q co-deletion) was never arranged — these markers can change the whole plan. Second, if surgery is being offered for a tumour near speech or movement areas without discussing safe-resection planning. Third, if brain metastases were offered whole-brain radiation without anyone mentioning stereotactic radiosurgery as an option. A review is also reasonable any time you feel rushed, unsure, or simply want a calm explanation before deciding.
Yes. A second opinion at CION is a review, not a commitment. We look at your MRI images, the radiology report, and any biopsy or pathology slides you bring, then explain what they mean in plain language and whether the proposed plan matches current NCCN and EANO guidance. You leave with a written summary you can take anywhere. There is no obligation to switch hospitals or begin treatment with us. You can read more about understanding your brain MRI and pathology report first.
Bring as much as you have, but do not delay the review if something is missing. Most helpful: the MRI scan images themselves (on CD, DVD, or as a digital link — not just the printed report), the radiologist's written MRI report, any biopsy or surgical pathology report and the glass slides or paraffin blocks if a biopsy was done, any molecular or genetic test results, your discharge summaries, and a list of current medicines including steroids and anti-seizure drugs. The actual MRI images matter most — a second-read radiologist often sees detail a report alone cannot convey.
Your scans and reports are reviewed by a radiation oncologist and medical oncologist, and where useful, re-read by a radiologist and neuropathologist. The case is then taken to CION's multidisciplinary tumour board, where specialists discuss whether the diagnosis, grade, and proposed plan fit current evidence. Any neurosurgery that may be needed is planned together with our accredited neurosurgical partners. You then get a 45-minute consultation and a written second opinion that clearly states what we agree with, what we would consider differently, and why.
In most cases, no — a well-run second opinion takes days, not weeks, and good decisions are rarely harmed by a short, deliberate pause. Brain tumours are managed by grade and type, and most plans allow time to confirm the diagnosis and arrange molecular testing before treatment begins. If your situation is genuinely urgent — for example, dangerous brain swelling or a fast-growing lesion — we will tell you honestly and fast-track the review. You can always request a callback or call us to understand the timeline for your specific case.
Yes to both. Your records and discussion stay confidential, and the second-opinion consultation is offered free — including a free written summary. Your current doctors do not need to be informed unless you choose to share the report with them. Many patients use the written second opinion precisely so they can have an informed conversation back with their original team. There is no commitment to start treatment at CION.
Absolutely. A large share of our second-opinion reviews are for patients first seen at other hospitals in Hyderabad, across Telangana and Andhra Pradesh, or in another city entirely. We routinely review outside scans and slides, and where appropriate we arrange a second-read of imaging and pathology. If you cannot travel, ask about a teleconsultation — many reviews start by sharing digital MRI images and reports. Explore our brain cancer specialists in Hyderabad to see who reviews your case.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.